TIGER 发表于 2025-3-23 12:05:59

http://reply.papertrans.cn/23/2219/221891/221891_11.png

万灵丹 发表于 2025-3-23 14:48:14

http://reply.papertrans.cn/23/2219/221891/221891_12.png

种植,培养 发表于 2025-3-23 18:08:27

https://doi.org/10.1007/BFb0016562 remain relatively understudied and unrecognized in heart failure. Literature from intensive care medicine, recognizes that an increase in IAP (defined as IAP > 8 mmHg), is an independent predictor for adverse outcome. A limited amount of data indicates that in ADHF, the prevalence of an IAP above 8

商品 发表于 2025-3-24 00:06:49

http://reply.papertrans.cn/23/2219/221891/221891_14.png

有法律效应 发表于 2025-3-24 04:34:03

http://reply.papertrans.cn/23/2219/221891/221891_15.png

踉跄 发表于 2025-3-24 09:46:30

https://doi.org/10.1007/978-4-431-55111-9ailure. Although irreversible renal dysfunction and treatment with renal replacement therapy are considered an absolute contraindication to left ventricular assist device (LVAD) implantation as destination therapy, advanced heart failure patients with recent onset renal dysfunction should not be exc

pacific 发表于 2025-3-24 11:01:51

http://reply.papertrans.cn/23/2219/221891/221891_17.png

Negligible 发表于 2025-3-24 16:29:10

http://reply.papertrans.cn/23/2219/221891/221891_18.png

THE 发表于 2025-3-24 19:54:56

http://reply.papertrans.cn/23/2219/221891/221891_19.png

Inscrutable 发表于 2025-3-25 00:52:41

W. H. Wilson Tang,Frederik H. Verbrugge,Wilfried MFeatures a multidisciplinary approach with contributions from both cardiologists and nephrologists.Contains a practically applicable case-based approach to managing patients with refractory congestion
页: 1 [2] 3 4 5 6
查看完整版本: Titlebook: Cardiorenal Syndrome in Heart Failure; W. H. Wilson Tang,Frederik H. Verbrugge,Wilfried M Book 2020 Springer Nature Switzerland AG 2020 Ca